KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Retained Earnings (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Retained Earnings for 17 consecutive years, with $169.0 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 1539.21% to $169.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $169.0 billion through Dec 2025, up 1539.21% year-over-year, with the annual reading at $169.0 billion for FY2025, 1539.21% up from the prior year.
  • Retained Earnings hit $169.0 billion in Q4 2025 for Johnson & Johnson, up from $167.3 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $169.0 billion in Q4 2025 to a low of -$15.3 billion in Q2 2021.
  • Historically, Retained Earnings has averaged $74.3 billion across 5 years, with a median of $121.1 billion in 2021.
  • Biggest five-year swings in Retained Earnings: plummeted 113.77% in 2021 and later soared 1539.21% in 2025.
  • Year by year, Retained Earnings stood at $121.1 billion in 2021, then plummeted by 112.63% to -$15.3 billion in 2022, then grew by 18.08% to -$12.5 billion in 2023, then grew by 6.27% to -$11.7 billion in 2024, then skyrocketed by 1539.21% to $169.0 billion in 2025.
  • Business Quant data shows Retained Earnings for JNJ at $169.0 billion in Q4 2025, $167.3 billion in Q3 2025, and $165.4 billion in Q2 2025.